VALENCIA, Calif., Nov. 25 MannKind Corporation(Nasdaq: MNKD), focused on discovering, developing and commercializingtreatments for diabetes and cancer, announced today that it will present atthe Piper Jaffray 20th Annual Health Care Conference on Tuesday, December 2,2008 at 2:30 PM (EST) at the New York Palace Hotel in New York City.
Interested parties can access a link to the live web cast of thepresentation in the Investor Relations section of the Company's website athttp://www.mannkindcorp.com. A replay of the presentation will be availablefor 14 days.
About MannKind Corporation
MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, developmentand commercialization of therapeutic products for patients with diseases suchas diabetes and cancer. Its pipeline includes AFRESA, which has completedPhase 3 clinical trials, and MKC253, which is currently in phase 1 clinicaltrials. Both of these investigational products are being evaluated for theirsafety and efficacy in the treatment of diabetes. MannKind maintains a websiteat https://www.mannkindcorp.com to which MannKind regularly posts copies ofits press release as well as additional information about MannKind.Interested persons can subscribe on the MannKind website to email alerts thatare sent automatically when MannKind issues press releases, files its reportswith the SEC or posts certain other information to the website.
SOURCE MannKind Corporation